MYD88 and ovarian carcinoma: For example, the TLR2-MyD88-NF-κB signaling pathway supports a proinflammatory microenvironment together with the expansion of the CD44+/MyD88+ epithelial ovarian cancer (EOC) stem cells by enhancing self-renewal, as shown by the upregulation of stemness-associated genes.